Enrollment of large, culturally diverse study populations allowed the examination ... their quota of patients was reached. Biphasic insulin aspart 30/70 was administered once, twice or three ...

Clin Drug Invest. 2004;24(12):695-717 ... and so the long-term effects of insulin aspart in CSII cannot be assessed. In addition, no studies have assessed the use of insulin aspart via CSII ...

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.